WHO ICTRP trial
Effect of New National Standard Infant Formula on the Growth and Development of…
ChiCTR2400089222 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2400089222 |
|---|---|
| Public title | Effect of New National Standard Infant Formula on the Growth and Development of Newborns with Cesarean Section |
| Scientific title | Effect of New National Standard Infant Formula on the Growth and Development of Newborns with Cesarean Section |
| Primary sponsor | Chengdu Women’s & Children’s Central Hospital |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Countries | China |
| Conditions | growth and development of children |
| Interventions | Formula intervention group:Use the free 1-stage infant formula provided in this study, which complies with the new national standard "National Food Safety Standard for Infants Aged 0-6 Months - Infant Formula Food" (GB10765-2021)… |
| Registration date | Sep 4, 2024 |
| Target size | Formula intervention group:50;Formula control group:50;Breastfeeding control… |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: